Equity Overview
Price & Market Data
Price: $0.0226
Daily Change: -$0.0₄58 / 0.26%
Range: $0.0178 - $0.0237
Market Cap: $9,919,967
Volume: 119,316
Performance Metrics
1 Week: -3.23%
1 Month: 207.7%
3 Months: 300.0%
6 Months: 263.6%
1 Year: 29.73%
YTD: 380.0%
Details
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; and Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases. Revive Therapeutics Ltd. is based in Toronto, Canada.